Quality of Life in CAPD, Transplant, and Chronic Renal Failure Patients with Diabetes

By Apostolou Theofanis   Hutchison Alastair   Boulton Andrew   Chak Willy   Vileikyte Loretta   Uttley Linda   Gokal Ram  

Renal Failure, Vol. 29, Iss. 2, 2007-02 ,pp. : 189-197

Informa Healthcare

Access to resources Recommend Favorite

Suppression of parathyroid hormone secretion in CAPD patients by intraperitoneal administration of Maxacalcitol

By Murakami Kazutaka   Miyachi Hiromi   Watanabe Asako   Kawamura Nahoko   Fujii Mikiko   Koide Shigehisa   Murase Masamitsu   Kushimoto Hiroko   Hasegawa Midori   Tomita Makoto   Hiki Yoshiyuki   Sugiyama Satoshi  

Clinical and Experimental Nephrology, Vol. 8, Iss. 2, 2004-06 ,pp. : 134-138

Springer Publishing Company

Access to resources Recommend Favorite

Glucose Concentration in the Dialysate does not Contribute to Lipid Profiles in Patients Undergoing CAPD

By Li Zheng   Fengxian Huang  

Renal Failure, Vol. 33, Iss. 2, 2011-03 ,pp. : 124-130

Informa Healthcare

Access to resources Recommend Favorite

TGF-β1 Gene Polymorphisms and Peritoneal Equilibration Test Results in CAPD Patients

By Ebinc Fatma Ayerden   Derici Ulver   Gonen Sevim   Reis Kadriye Altok   Erten Yasemin   Bali Musa   Sindel Sukru   Arinsoy Turgay  

Renal Failure, Vol. 30, Iss. 1, 2008-01 ,pp. : 15-19

Informa Healthcare

Access to resources Recommend Favorite

Commencing peritoneal dialysis with 1.1% amino acid solution does not influence biochemical nutritional parameters in incident CAPD patients

By Dervisoglu Erkan   Ozdemir Ozlem   Yilmaz Ahmet  

Renal Failure, Vol. 32, Iss. 6, 2010-07 ,pp. : 653-658

Informa Healthcare

Access to resources Recommend Favorite